Rite Aid Reports Net Income of $21.5 Million and Adjusted EBITDA of $346.8 Million for Second Quarter Fiscal 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Mizuho Securities Reiterates Buy on Rite Aid (RAD) Following 2Q16
September 17, 2015 2:29 PM EDTMizuho Securities reiterated a Buy rating and $10.00 price target on Rite-Aid (NYSE: RAD) following the company's 2Q16 earnings results. RAD reported adjusted EBITDA of $346.8mm was modestly above consensus of $344.2mm.
Analyst Ann Hynes commented, "We would be buyers of RAD on earnings-related... More
Cowen Remains Bullish on Rite Aid (RAD) Following 2c EPS Miss
September 17, 2015 1:13 PM EDTCowen reiterated an Outperform rating and $12.00 price target on Rite-Aid (NYSE: RAD) following the company's 2Q16 earnings. RAD reported EPS of $0.02, which missed consensus of $0.04. Rev of $7.66B, consisting of $6.65B from retail pharmacy and $1.07B from pharmacy services, came in ahead of... More
Rite Aid (RAD) Misses Q2 EPS by 2c; Trims FY16 EPS Outlook
September 17, 2015 7:02 AM EDTRite Aid (NYSE: RAD) reported Q2 EPS of $0.02, $0.02 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $7.7 billion versus the consensus estimate of $7.57 billion.
Same store drugstore sales for the Retail Pharmacy Segment increased 2.1 percent over the prior year,... More

